Gary B. Gordon - 29 Jan 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ James E. Young, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
29 Jan 2025
Net transactions value
$0
Form type
4
Filing time
31 Jan 2025, 18:05:15 UTC
Previous filing
23 Jan 2023
Next filing
27 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Director Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 29 Jan 2025 Common Stock 35,000 $4.89 Direct F1
transaction TLSI Director Stock Option (right to buy) Award $0 +6,250 $0.000000 6,250 29 Jan 2025 Common Stock 6,250 $4.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 The shares subject to the option shall fully vest on the one-year anniversary of the grant date of January 29, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.